Effects of Rapamycin on Ryanodine Receptor/Ca2+-Release Channels from Cardiac Muscle

Circulation Research

Volumn 78, Issue 6, 1996, Pages 990-997

  Kaftan, Edward ^a   Marks, Andrew R ^b   Ehrlich, Barbara E ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

FK506; Fk506 binding protein; Immunosuppressive therapy; Intracellular channels

Indexed keywords

CALCIUM CHANNEL; CYCLOPHILIN; IMMUNOPHILIN; INOSITOL 1,4,5 TRISPHOSPHATE; ISOMERASE; RAPAMYCIN; RYANODINE RECEPTOR; TACROLIMUS;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CHANNEL GATING; CONTROLLED STUDY; DOG; DRUG EFFECT; HEART MUSCLE CONTRACTILITY; IMMUNOSUPPRESSIVE TREATMENT; LIPID BILAYER; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SARCOPLASMIC RETICULUM;

ANIMALS; CALCIUM CHANNELS; CARRIER PROTEINS; DNA-BINDING PROTEINS; DOGS; HEART; HEAT-SHOCK PROTEINS; IMMUNOSUPPRESSIVE AGENTS; MUSCLE PROTEINS; POLYENES; RYANODINE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SIROLIMUS; TACROLIMUS BINDING PROTEINS;

EID: 0029934608     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.78.6.990     Document Type: Article

References (56)

1. Fleischer S, Inui M. Biochemistry and biophysics of excitation-contraction coupling. Annu Rev Biophys Biophys Chem. 1989;18: 333-364.
2. 2+ release channels and their regulation by endogenous effectors. Annu Rev Physiol. 1994;56: 485-508.
3. Coronado R, Morrissette J, Sukhareva M, Vaughan DM. Structure and function of ryanodine receptors. Am J Physiol. 1994;266: C1485-C1504.
4. Catterall WA. Excitation-contraction coupling in vertebrate skeletal muscle: a tale of two calcium channels. Cell. 1991;64: 871-874.
5. Rios E, Ma J, Gonzalez A. The mechanical hypothesis of excitation-contraction (EC) coupling in skeletal muscle. J Muscle Res Cell Motil. 1991;12:127-135.
6. Franzini-Armstrong C, Jorgensen AO. Structure and development of E-C coupling units in skeletal muscle. Annu Rev Physiol. 1994;56: 509-534.
7. 2+ release channel. J Biol Chem. 1993;268:13765-13768.
8. Ellisman MH, Deerinck TJ, Ouyang Y, Beck CF, Tanksley SJ, Walton PD, Airey JA, Sutko JL. Identification and localization of ryanodine binding proteins in the avian central nervous system. Neuron. 1990;5:135-146.
9. Gallone A. Ca-induced Ca release and its modulation by cyclic ADP-ribose. Trends Pharmacol Sci. 1992;13:304-306.
10. Lee HC, Aarhus R, Walseth TF. Calcium mobilization by dual receptors during fertilization of sea urchin eggs. Science. 1993;261: 352-355.
11. Inui M, Saito A, Fleischer S. Purification of the ryanodine receptor and identity with feet structures of junctional terminal cisternae of sarcoplasmic reticulum from fast skeletal muscle. J Biol Chem. 1987;262:1740-1747.
12. Lai FA, Erickson HP, Rousseau E, Liu Q-Y, Meissner G. Purification and reconstitution of the calcium release channel from skeletal muscle. Nature. 1988;331:315-319.
13. Smith JS, Imagawa T, Ma J, Fill M, Campbell KP, Coronado R. Purified ryanodine receptor from rabbit skeletal muscle is the calcium release-channel of sarcoplasmic reticulum. J Gen Physiol. 1988;92:1-26.
14. 2+. J Gen Physiol. 1986;88:573-588.
15. Imagawa T, Smith J, Coronado R, Campbell K. Purified ryanodine receptor from skeletal muscle sarcoplasmic reticulum is the Ca-permeable pore of the calcium release channel. J Biol Chem. 1987; 262:16636-16643.
16. 2+ flux measurements of the cardiac sarcoplasmic reticulum calcium channel. Biophys J. 1986;50:1009-1014.
17. Ehrlich BE, Watras J. Inositol 1,4,5-trisphosphate activates a channel from smooth muscle sarcoplasmic reticulum. Nature. 1988; 336:583-586.
18. Lindsay ARG, Williams AJ. Functional characterisation of the ryanodine receptor purified from sheep cardiac muscle sarcoplasmic reticulum. Biochim Biophys Acta. 1991;1064:89-102.
19. Marks AR, Tempst P, Hwang KS, Taubman MB, Inui M, Chadwick C, Fleischer S, Nadal-Ginard B. Molecular cloning and characterization of the ryanodine receptor/junctional channel complex cDNA from skeletal muscle sarcoplasmic reticulum. Proc Natl Acad Sci U S A. 1989;86:8683-8687.
20. Takeshima H, Nishimura S, Matsumoto T, Ishida H, Kangawa K, Minamino N, Matsuo H, Ueda M, Hanaoka M, Hirose T, Numa S. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature. 1989;339:439-445.
21. Zorzato F, Fujii J, Otsu K, Phillips M, Green NM, Lai FA, Meissner G, MacLennan DH. Molecular cloning of cDNA encoding human and rabbit forms of the Ca release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J Biol Chem. 1990;265:2244-2256.
22. Nakai J, Imagawa T, Hakamata Y, Shigekawa M, Takeshima H, Numa H. Primary structure and functional expression from cDNA of the cardiac ryanodine receptor/calcium release channel. FEBS Lett. 1990;271:169-177.
23. 2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J Biol Chem. 1990;265:13472-13483.
24. 2+-release channels. Trends Phamacol Sci. 1994;15:145-149.
25. Jayaraman T, Brillantes AM, Timerman AP, Fleischer S, Erdjumentbromage H, Tempst P, Marks AR. FK506 binding protein associated with the calcium release channel (ryanodine receptor). J Biol Chem. 1992;267:9474-9477.
26. Harding MW, Galat A, Uehling DE, Schreiber SL. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature. 1989;341:758-760.
27. Bierer B, Somers PK, Wandless TJ, Burakoff SJ, Schreiber SL. Probing immunosuppressant action with a nonnatural immunophilin ligand. Science. 1990;250:556-559.
28. Bierer BE, Mattilia PS, Standaert R, Herzenberg L, Burakoff S, Crabtree G, Schreiber S. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc Natl Acad Sci USA. 1990;87:9231-9235.
29. Dumont FJ, Staruch MJ, Kooprak SL, Melino MR, Sigal NH. Distinct mechanisms of suppression of murine T-cell activation by the related macrolides FK-506 and rapamycin. J Immunol. 1990; 144:251-258.
30. Schreiber S. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science. 1991;251:283-287.
31. Chung J, Kuo CJ, Crabtree GR, Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation of and signalling the 70 kDa S6 protein kinases. Cell. 1992;69:1227-1236.
32. Kuo CJ, Chung J, Fiorentino DF, Flanagan WM, Blenis J, Crabtree GR. Rapamycin selectively inhibits interleukin-2 activation and p70 S6 kinase 1. Nature. 1992;358:70-73.
33. Price DJ, Grove JR, Calvo V, Avruch J, Bierer BE. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science. 1992;257:973-977.
34. Jayaraman T, Marks AR. Rapamycin-FKBP blocks proliferation and inhibits cdc2 kinase activity in a myogenic cell line. J Biol Chem. 1993;268:25385-25388.
35. Morice WG, Brunn GJ, Wiederrecht G, Siekierka JJ, Abraham RT. Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes. J Biol Chem. 1993;268:3734-3738.
36. Brown E, Albers M, Shin T, Ichikawa K, Keith C, Lane W, Schreiber S. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature. 1994;369:756-758.
37. Sabatini D, Erdjument-Bromage H, Lui M, Tempst P, Snyder S. RAFT1: a mammalian protein that binds FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell. 1994;78: 35-43.
38. Brillantes A-MB, Ondrias K, Scott A, Kobrinsky E, Ondriasova E, Moschella MC, Jayaraman T, Landers M, Ehrlich BE, Marks AR. Stabilization of calcium release channel (ryanodine receptor) function by FK-506 binding protein. Cell. 1994;77:513-523.
39. Leiva MC, Lyttle CR. Leukocyte chemotactic activity of FKBP and inhibition by FK506. Biochem Biophys Res Commun. 1992;186: 1178-1183.
40. Cameron AM, Steiner JP, Sabatini DM, Kaplin AI, Walensky LD, Snyder SH. Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux. Proc Natl Acad Sci U S A. 1995;92:1784-1788.
41. Timerman AP, Jayaraman T, Wiederrecht G, Onoue H, Marks AR, Fleischer S. The ryanodine receptor from canine heart sarcoplasmic reticulum is associated with a novel FK-506 binding protein. Biochem Biophys Res Commun. 1994;198:701-706.
42. Sewell TJ, Lam E, Martin MM, Leszyk J, Weidner J, Calaycay J, Griffin P, Williams H, Hung S, Cryan J, Sigal NH, Wiederrecht GJ. Inhibition of calcineurin by a novel FK-506-binding protein. J Biol Chem. 1994;269:21094-21102.
43. Ondrias K, Borgatta L, Kim DH, Ehrlich BE. Biphasic effects of doxorubicin on the calcium release channel from sarcoplasmic reticulum of cardiac muscle. Circ Res. 1990;67:1167-1174.
44. Fabiato A. Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. Methods Enzymol. 1988;157:378-417.
45. Mayrleitner M, Timerman AP, Wiederrecht G, Fleischer S. The calcium release channel of sarcoplasmic reticulum is modulated by FK-506 binding protein: effect of FKBP-12 on single channel activity of the skeletal muscle ryanodine receptor. Cell Calcium. 1994;15:99-108.
46. Ahern GP, Junankar PR, Dulhunty AF. Single channel activity of the ryanodine receptor calcium release channel is modulated by FK-506. FEBS Lett. 1994;352:369-374.
47. Pessah IN, Waterhouse AL, Casida JE. The calcium-ryanodine receptor complex of skeletal and cardiac muscle. Biochem Biophys Res Commun. 1985;128:449-456.
48. +2 release channel complex. J Biol Chem. 1989;264:1329-1335.
49. 2+-release channel in malignant hyperthermia. J Biol Chem. 1992;267:6702-6709.
50. Timerman AP, Ogunbunmi E, Freund E, Wiederrecht G, Marks A, Fleischer S. The calcium release channel of sarcoplasmic reticulum is modulated by FK-506 binding protein. J Biol Chem. 1993;268: 22992-22999.
51. Liu J, Farmer J, Lane W, Freidman J, Weissman I, Schreiber S. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991;66:807-815.
52. Kunz J, Henriquez R, Schneider U, Deuter-Reinhard M, Mowa NR, Hall MN. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell. 1993;73:585-596.
53. Wang T, Donahoe PK, Zervos AS. Specific interaction of type 1 receptors of the TGF-beta family with the immunophilin FKBP-12. Science. 1994;265:674-676.
54. Mack MM, Molinski TF, Buck ED, Pessah IN. Novel modulators of skeletal muscle FKBP12/calcium channel complex from Ianthella basta. J Biol Chem. 1994;269:23236-23249.
55. Timerman AP, Wiederrecht G, Marcy A, Fleischer S. Characterization of an exchange reaction between soluble FKBP-12 and the FKBP-ryanodine receptor complex. J Biol Chem. 1995;270: 2451-2459.
56. Morris R. Rapamycins: antifungal, antiproliferative, and immunosuppressive macrolides. Transplant Rev. 1992;6:39-87.